Molecular model of cyclin-dependent kinase 5 complexed with roscovitine


Autoria(s): de Azevedo, W. F.; Gaspar, R. T.; Canduri, F.; Camera, J. C.; da Silveira, NJF
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

11/10/2002

Resumo

Here is described a structural model for the binary complex CDK5-roscovitine. Roscovitine has been shown to potently inhibit cyclin-dependent kinases 1, 2 and 5 (CDK1, 2, and 5), and the structure of CDK2 complexed with roscovitine has been reported; however, no structural data, are available for complexes of CDK5 with inhibitors. The structural model indicates that roscovitine strongly binds to the ATP-binding pocket of CDK5 and structural comparison of the CDK2-roscovitine complex correlates the structural differences with differences in inhibition of these CDKs by this inhibitor. This structure opens the possibility of testing new inhibitor families, in addition to new substituents for the already known lead structures of adenine derivatives. (C) 2002 Elsevier B.V. (USA). All rights reserved.

Formato

1154-1158

Identificador

http://dx.doi.org/10.1016/S0006-291X(02)02352-5

Biochemical and Biophysical Research Communications. San Diego: Academic Press Inc. Elsevier B.V., v. 297, n. 5, p. 1154-1158, 2002.

0006-291X

http://hdl.handle.net/11449/39148

10.1016/S0006-291X(02)02352-5

WOS:000178692800014

Idioma(s)

eng

Publicador

Elsevier B.V.

Relação

Biochemical and Biophysical Research Communications

Direitos

closedAccess

Palavras-Chave #CDK #Roscovitine #bioinformatics #Structure #drug design
Tipo

info:eu-repo/semantics/article